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OBJECTIVE To compare the prognostic significance of reperfusion assessment by Thrombolysis in
Myocardial Infarction (TIMI) flow grade in the infarct related artery and ST-segment
resolution analysis, by correlating with clinical outcomes in patients with acute myocardial
infarction (AMI).
BACKGROUND Angiographic assessment, based on epicardial coronary anatomy, has been considered the
“gold standard” for reperfusion. The electrocardiogram (ECG) monitoring provides a
noninvasive, real-time physiologic marker of cellular reperfusion and may better predict
clinical outcomes.
METHODS Two hundred fifty-eight AMI patients from the Thrombolytics and Myocardia Infarction
phase 7 and Global Utilization of Streptokinase tPA for Occluded coronary arteries phase 1
trials were stratified based on blinded, simultaneous reperfusion assessment on the acute
angiogram (divided into TIMI grades 0 & 1, TIMI grade 2 and TIMI grade 3) and
ST-segment resolution analysis (divided into: ,50% ST-segment elevation resolution or
reelevation and $50% ST-segment elevation resolution). In-hospital mortality, congestive
heart failure (CHF) and combined mortality or CHF were compared to determine the
prognostic significance of reperfusion assessment by each modality using chi-square and
Fisher’s Exact tests for univariable correlation and logistic regression analysis for univariable
and multivariable prediction models.
RESULTS By logistic regression analysis, ST-segment resolution patterns were an independent predictor
of the combined outcome of mortality or CHF (p 5 0.024), whereas TIMI flow grade was
not (p 5 0.693). Among the patients determined to have failed reperfusion by TIMI flow
grade assessment (TIMI flow grade 0 & 1), the ST-segment resolution of $50% identified
a subgroup with relatively benign outcomes with the incidence of the combined end point of
mortality or CHF 17.2% versus 37.2% in those without ST-segment resolution (p 5 0.06).
CONCLUSION Continuous 12-lead ECG monitoring can be an inexpensive and reliable modality for
monitoring nutritive reperfusion status and to obtain prognostic information in patients with
AMI. (J Am Coll Cardiol 2000;35:666–72) © 2000 by the American College of Cardiology
In previous studies, the incidence of failed reperfusion after
thrombolytic therapy has ranged from 15% to 50% (1,2). Of
the many diagnostic modalities currently employed for the
assessment of reperfusion, coronary angiography has been
considered the “gold standard” (3–5). Although several
noninvasive markers for reperfusion have been described,
the accuracy of these techniques is judged based on their
correlation with angiographic findings.
Angiographic assessment is based on the Thrombolysis in
Myocardial Infarction (TIMI) flow grade determination in
the epicardial infarct related artery (IRA). However, epicar-
dial coronary patency may not mean nutritive cellular
perfusion. Additionally, an angiographic “snapshot” of cor-
onary anatomy cannot describe the fluctuations in coronary
flow over time that have been reported during the acute
phase of myocardial infarction in 35% to 50% of patients
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(2,6). In contrast, the ST-segment changes observed by
electrocardiogram (ECG) monitoring can potentially pro-
vide a continuous, noninvasive, real time physiologic marker
of nutritive cellular reperfusion.
We hypothesized that electrocardiographically deter-
mined reperfusion status might be more predictive of
clinical outcomes than angiography. The purpose of this
study was to compare the prognostic significance of simul-
taneous reperfusion assessment by angiographic TIMI flow
grade in the IRA versus electrocardiographic ST-segment
elevation resolution analysis in patients with acute myocar-
dial infarction (AMI).
METHODS
Patient population. All 258 patients who had continuous
12-lead ECG monitoring and protocol acute angiography
during the Thrombolytics and Angioplasty in Myocardial
Infarction phase 7 (TAMI-7, n 5 143) and Global Utili-
zation of Streptokinase tPA for Occluded coronary arteries
phase 1 (GUSTO-1, n 5 115) trials were included in this
study. Inclusion and exclusion criteria for the TAMI-7 and
GUSTO-1 trials have been published previously (7,8). All
participating patients had provided informed consent for
participating in TAMI-7 and GUSTO-1 studies. Inclusion
in this study required QRS duration of 120 ms or less.
Patients with marked conduction system abnormalities that
rendered ECG analysis impossible were excluded from our
study.
Baseline characteristics. Data on the following baseline
demographic and cardiac risk factor characteristics were
provided by the cardiovascular databank at the Duke Uni-
versity Medical Center: time from the onset of symptoms to
initiation of thrombolytic therapy, age, height, weight,
history of hypertension, diabetes, myocardial infarction,
angioplasty, bypass surgery and smoking. Additionally, the
peak creatinine phosphokinase (CPK) levels, angiographi-
cally determined IRA, left ventricular ejection fraction
(LVEF) and the number of major coronary arteries with
$50% luminal stenosis were included as baseline descrip-
tors.
Angiography. In accordance with the TAMI-7 and
GUSTO-1 protocols, all patients had acute coronary an-
giography performed (after informed consent) 90–180 min
after the start of thrombolytic therapy (7,9). Infarct related
artery TIMI flow grade for TAMI-7 patients was deter-
mined at the angiographic core laboratory at the University
of Michigan Hospital; that for GUSTO-1 patients was
determined at the angiographic core laboratory at George
Washington University Hospital. For the purposes of our
study, patients were divided into three groups: 1) TIMI
grade flow 0 & 1, 2) TIMI flow grade 2, and 3) TIMI flow
grade 3.
Continuous 12-lead ECG monitoring. All patients in
this study had continuous 12-lead ECG monitoring using a
portable digital instrument (ST100, Mortara Instrument,
Milwaukee, Wisconsin) (2). Monitoring was initiated at
median (25th, 75th percentiles) of 3.46 min (29.33 min,
21.22 min) after the start of thrombolytic therapy and
continued for median (25th, 75th percentiles) of 25.17
(12.19, 41.48) hours. All ST-segment monitoring data were
analyzed at the Ischemia Monitoring Laboratory, Duke
University Medical Center by a single experienced physi-
cian, blinded to all clinical and angiographic data. Assess-
ment of each patient’s ST-segment resolution at the time of
protocol angiography was performed using the previously
published continuous ST-segment resolution analysis
method (10). Patients were divided into two groups: 1)
those with either less than 50% resolution of the ST-
segment elevation from the peak ST-segment elevation in
the lead showing the greatest ST-segment elevation, or
150 mV or $, and 2) those with 50% or more ST-segment
elevation resolution (without reelevation). In order to de-
termine reperfusion status simultaneous with angiography,
all analyses were based on continuous ECG data until
within 5 min of the initial angiographic contrast injection.
The 5 min window was allowed for any possible clock
discrepancy. The physician analyzing the ST-segment data
was kept blinded to all the continuous ECG data subse-
quent to the time of initial angiographic contrast injection.
Outcomes. Data for the outcomes were provided by the
coordinating center for TAMI-7 and GUSTO-1 trials at
Duke University Medical Center. For the purpose of this
study, the following parameters were analyzed as outcomes:
in-hospital all-cause mortality, the incidence of new con-
gestive heart failure (CHF), and the “combined end point”
of mortality or CHF.
Statistical analyses. Data for baseline and clinical outcome
parameters are reported using percentages for categorical
variables and 50th (25th, 75th) percentiles for continuous
variables. To determine possible univariate correlates of
adverse cardiac outcomes and ST-segment/TIMI flow
grade category, we applied the chi-square and Fisher’s exact
test for categorical variables. A p value of ,0.05 was
considered statistically significant. The sample sizes and
Abbreviations and Acronyms
AMI 5 acute myocardial infarction
CHF 5 congestive heart failure
CPK 5 creatinine phosphokinase
ECG 5 electrocardiogram
GUSTO-1 5 Global Utilization of Streptokinase tPA
for Occluded coronary arteries phase 1
IRA 5 infarct related artery
LVEF 5 left ventricular ejection fraction
TAMI-7 5 Thrombolytics and Myocardia Infarction
phase 7
TIMI 5 Thrombolysis in Myocardial Infarction
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events rates were small in some subgroups; thus, 95%
confidence intervals were also given for the event to show
how much variability exists. We used exact binomial distri-
bution to find the 95% confidence intervals. A family of
comparisons was not used since we were not comparing
multiple TIMI flow grades subgroups to one another. We
were comparing two ST-segment resolution categories
within each TIMI flow grade subgroup. We thought that
utilizing 95% confidence intervals was more informative. A
logistic regression model was used to determine if ST-
segment resolution analysis, rather than TIMI flow grade
determination, more accurately predicts the combined end
point. Stepwise regression was not used. Multicollinearity
was not a factor since TIMI flow was not an independent
predictor and stepwise regression was not used.
RESULTS
Baseline characteristics. Tables 1 and 2 present the base-
line characteristics among the ST-segment resolution and
TIMI flow groups.
Outcomes. Table 3 shows outcomes for all the subgroups
based on TIMI flow grade categories and ST-segment
elevation resolution characteristics:
1) When patients were classified according to TIMI flow
grade, outcomes were comparable among all three
groups. In patients with TIMI flow grade 0/1, TIMI
flow grade 2 and TIMI flow grade 3, the incidence of
in-hospital, all-cause mortality was 7.5%, 8.7% and
6.4%, respectively (p 5 0.851); the incidence of CHF
was 27.5%, 24.6% and 24.8%, respectively (p 5 0.894),
and incidence of the combined end point was 30.0%,
29.0% and 24.8%, respectively (p 5 0.693). When the
patients with TIMI flow grades 0/1 and 2 were subdi-
vided according to the ST-segment elevation resolution
or persistence, those with the persistence of ST-segment
elevation had a striking trend toward worse outcomes in
all three parameters, compared with those with the
resolution of ST-segment elevation. Almost all the
patients (96.3%) with TIMI flow grade 3 had resolution
of ST-segment elevation.
2) When patients were classified according to the ST-
segment elevation resolution, compared with patients
with ST-segment elevation resolution, those with per-
sistent ST-segment elevation had trends toward worse
outcomes regarding either the incidence of in-hospital
all-cause mortality (6.1% vs. 11.3%, p 5 0.174) or the
incidence of CHF (23.0% vs. 33.9%, p 5 0.085). The
incidence of the combined end point was significantly
different between the two groups (24.0% vs. 38.7%, p 5
0.024).
3) Table 4 shows the comparison using the logistic regres-
sion models of the ST-segment to IRA TIMI grade flow
for the prediction of the combined end point. ST-
segment elevation status was an independent predictor of
the combined end point (p 5 0.024); TIMI grade flow
was not (p 5 0.693). When both variables were included
in a single logistic regression model, ST-segment reso-
lution added additional information TIMI flow grade
(p 5 0.017). When TIMI grade flow information was
added to ST-segment resolution analysis results, no
additional prognostic information was gained.
DISCUSSION
No previous study has compared the relative prognostic
significance of reperfusion assessments by angiography ver-
sus continuous ECG, using clinical outcomes as the stan-
dard. In the past, angiographic findings were used as the
“gold standard” to assess the findings of other (noninvasive)
techniques. In cases of discordance between angiographic
and ECG findings, angiographic findings were considered
more reliable. Angiographic epicardial coronary artery pa-
tency status may not correspond with the presence or
absence of nutritive perfusion at the cellular level. This has
been demonstrated in some studies in which discrepancies
between outcomes and angiographic evidence of reperfusion
were explained as “no-reflow” or “reperfusion injury” phe-
nomena (11,12). Similarly in our study, IRA TIMI flow
grade assessment alone was not useful to risk stratify
patients, as evidenced by comparable outcomes among
patients with all three categories of TIMI flow grade.
The results of our study support the hypothesis that
ST-segment resolution as a continuous, physiologic marker
of reperfusion predicts outcomes better than a transient,
anatomic marker such as angiographic TIMI flow grade in
the IRA. Outcomes in our study population did not differ
significantly when grouped according to TIMI flow grade
although there were trends toward better outcomes in
patients with TIMI 3 flow grade compared with those with
TIMI grades #2 flow. Conversely, when grouped according
to ST-segment elevation resolution characteristics, patients
whose ST-segment elevation resolved had significantly
lower incidence of the combined end point than those
whose ST-segment elevation persisted. Similarly, logistic
regression analysis indicated ST-segment resolution to be
an independent predictor of the combined end point; TIMI
grade flow was not an independent predictor and did not
add to the information from ST-segment resolution analy-
sis. These results become more significant when one con-
siders that the continuous ECG data for the time after the
TIMI flow grade determination were not allowed to be used
for patient prognostic stratification. This censoring of avail-
able data provided myocardial reperfusion by angiography
and ECG, based only on the data obtained until a specific
point in time. However, in clinical settings, the continuous
ECG monitoring can describe dynamic ST-segment
changes even after angiographic determination of coronary
anatomy.
Within each TIMI flow grade category (0/1, 2 and 3),
patients with ST-segment elevation resolution had trends
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toward lower incidence of all outcome parameters compared
with those with persistent ST-segment elevation. However,
due to small numbers in patient subgroups, any concrete
conclusions are not possible. These results suggest that
when clinical outcomes are used as the standard, TIMI
grade 3 flow is a specific, though not a sensitive, marker for
successful reperfusion. In our study, angiography failed to
distinguish patients with good outcomes among those with
TIMI grades ,3 flow. However, continuous ECG moni-
toring was both a specific and a sensitive predictor of clinical
outcomes.
It is noteworthy that in our study the in-hospital mor-
tality rate in patients with TIMI flow grade 3 was 6.4%—
higher than the 4.4% rate reported in the GUSTO angio-
graphic substudy (9). The reasons for this difference cannot
be fully explained but could be due to a smaller sample size
or due to the fact that patients from both TAMI-7 and
GUSTO-1 trials were included. However, it is important to
point out that both mortality rate and the incidence of CHF
were always concordant in prognostication of every patient
group, emphasizing the validity of outcome data in our
population. Similarly, as opposed to our study, GUSTO
angiographic study showed TIMI flow grade to correlate
with in-hospital mortality. We are unable to fully explain
the difference in findings of the two studies. Smaller sample
size and inclusion of TAMI-7 patients in our study could, at
least in part, explain the difference. It is noteworthy that
even in our study, TIMI flow grade 3 was a specific marker
for “good outcomes.” However, it was not a sensitive
marker, whereas, the resolution of ST-segment was a
sensitive as well as specific predictor of “good outcomes.”
TIMI flow grade 2. At the time of the TAMI-7 and
GUSTO-1 trials, TIMI flow grade 2 was clinically consid-
ered a marker of successful reperfusion. This study consid-
ered these patients as a separate group, based on several
reports of outcomes in patients with TIMI grade flow 2
intermediate between those with TIMI flow grades 0/1 and
3 and significantly worse than those with TIMI flow grade
3 (13–18). The results of our study suggest that TIMI flow
Table 2. Baseline Characteristics According to the ST-Segment Resolution Patterns
Group/Variable
Persistence of
ST-Segment Elevation
Resolution of
ST-Segment Elevation
N 62 196
Age (yr) 56 (45, 64) 60 (50, 69)
Time to treat (h)* 2.1 (1.6, 2.8) 2.9 (2.0, 4.0)
Height (cms) 177 (170, 183) 175 (168, 180)
Weight (kg) 85 (73, 97) 80 (72, 91)
Hypertension 20 (32.3%) 80 (40.8%)
Diabetes mellitus 10 (16.1%) 33 (16.8%)
Previous MI 2 (3.2%) 22 (11.2%)
Previous PTCA 1 (1.6%) 6 (3.1%)
Previous CABG 1 (1.6%) 3 (1.5%)
Previous CVD** 3 (4.9%) 3 (1.5%)
Smoking history 51 (82.3%) 136 (69.4%)
IRA*** n 5 62 n 5 196
LAD 19 (30.6%) 85 (43.4%)
LCx 8 (12.9%) 23 (11.7%)
RCA 32 (51.6%) 84 (42.9%)
Other 3 (4.8%) 4 (2.0%)
Time until monitor hookup
(min)#
0.9 (28.8, 22.8) 3.9 (211.7, 19.0)
Time until monitor
disconnected (h)##
22.3 (4.8, 41.2) 26.0 (16.4, 41.7)
Peak CPK 2,164 (1,026, 3,919) 1,784 (767, 3,200)
Left ventricular ejection fraction n 5 34
52 (41, 60)
n 5 103
(53 (43, 60)
Number of diseased n 5 61 n 5 190
Coronary arteries
0 4 (6.6%) 6 (3.2%)
1 39 (63.9%) 91 (47.9%)
2 12 (19.7%) 60 (31.6%)
3 6 (9.8%) 33 (17.4%)
Data for baseline and clinical outcome parameters are reported using percentages for categorical variables and 50th (25th, 75th)
percentiles for continuous variables. *Time from the onset of symptoms to the start of thrombolytic therapy; **previous
cerebrovascular disease; ***infarct related artery. #Time from the onset of symptoms to the start of continuous ECG monitoring;
##duration of continuous ECG monitoring. Abbreviations as in Table 1A.
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grade 2 is a marker of high risk in some and low risk in
others. Although pathophysiology is not considered in this
study, in some patients with TIMI flow grade 2, benefits
from partial reperfusion may be outweighed by possible
risks, such as reperfusion injury. In others, TIMI flow grade
2 would actually be associated with nutritive cellular reper-
fusion. ST-segment elevation resolution characteristics may
help ascertain the true clinical significance of TIMI flow
grade 2 in an individual. However, these results regarding
TIMI grade 2 flow should be viewed with consideration of
the small number of such patients in this population.
Results of our study suggest that “angiographic reperfu-
sion” may not be synonymous with nutritive cellular reper-
fusion. Angiography does not provide any physiologic
markers of cellular reperfusion and only provides brief
visualization of epicardial anatomy. Additionally, the inva-
sive and expensive nature of the acute angiography places
practical limits on its routine applicability for patients with
AMI, especially in the current era of healthcare economics.
Obviously, electrocardiographic monitoring is not a substi-
tute for the angiographic data in every patient with AMI.
However, in many patients, information obtained through
electrocardiographic monitoring can potentially be used to
identify patients who need an acute angiogram instead of
conservative observation, and in other patients, this infor-
mation could supplement angiographic data, in acute care
and risk stratification.
Study limitations. Although our study was retrospective,
it was based on blinded analysis of predefined angio-
graphic, electrocardiographic and clinical variables. The
study population was relatively small to address all the issues
discussed, characterize other subtle bias and multivariate
analysis regarding baseline characteristics. Additionally, col-
lateral blood flow information was unavailable for consid-
eration while making angiography-based decisions. Only
50% level of ST-segment elevation resolution was evaluated
in this study. Other degrees of ST-segment resolution may
indeed have prognostic values. Because of these limitations,
validation of our findings in a larger prospective study will
be required.
Table 3. Outcomes
Group/Variable TIMI 0/1 TIMI 2 TIMI 3
All TIMI
Flows
N 80 69 109 258
Persistence of ST-Elevation n 5 51 n 5 7 n 5 4 n 5 62
Mortality 5 (9.8%) 2 (28.6%) 0 (0%) 7 (11.3%)
CHF 17 (33.3%) 3 (42.9%) 1 (25.0%) 21 (33.9%)
Mortality or CHF 19 (37.2%)* 4 (57.1%)** 1 (25.0%)*** 24 (38.7%)†
95% CI (26.0%, 49.5%) (19.0%, 90.0%) (0.5%, 80.5%) 28.5%, 49.5%)
Resolution of ST-Elevation n 5 29 n 5 62 n 5 105 n 5 196
Mortality 1 (3.4%) 4 (6.4%) 7 (6.7%) 12 (6.1%)
CHF 5 (17.2%) 14 (22.6%) 26 (24.8%) 45 (23%)
Mortality or CHF 5 (17.2%)* 16 (25.8%)** 26 (24.8%)*** 47 (24%)†
95% CI (6.0%, 34.5%) (16.5%, 36.5%) (18.0%, 32.0%) (19.5%, 28.5%)
All ST-Segment Categories n 5 80 n 5 69 n 5 109 n 5 258
Mortality 6 (7.5%) 6 (8.7%) 7 (6.4%) 19 (7.4%)
CHF 22 (27.5%) 17 (24.6%) 27 (24.8%) 66 (25.6%)
Mortality or CHF 24 (30%)†† 20 (29.0%)†† 27 (24.8%)†† 71 (27.5%)
95% CI (22.0%, 39.0%) (20.0%, 39.0%) (18.5%, 32.0%) (24.0%, 31.5%)
All the p values and 95% confidence intervals are for the combined end point of in-hospital mortality or CHF. *p value 5 0.060 by chi-square test; **p value 5 0.180 by Fisher’s
exact test; ***p value 5 1.0 by Fisher’s exact test; †p value 5 0.024 by chi-square test; ††p value 5 0.693 by chi-square test.
CHF 5 congestive heart failure; CI 5 confidence intervals; TIMI 5 Thrombolysis in Myocardial Infarction.
Table 4. Logistic Regression Models
Univariable Regression
Model
Model
Chi-Square p Value
TIMI flow grade only 0.734* 0.6928
ST-segment resolution category only 5.124 0.0236
Multivariable Regression: Model Chi-Square 5 6.384
Variable
Wald
Chi-Square p Value
TIMI flow grade
0/1 vs. 2 1.262 0.2613
0/1 vs. 3 0.654 0.4188
ST-segment resolution category 5.277 0.0216
Regression Models are for the combined end point of in-hospital mortality or CHF.
TIMI flow grade in the infarct related artery (IRA) is not an independent predictor
of the combined end point, while ST-segment elevation resolution category is an
independent predictor. When IRA TIMI flow grade information is added to
ST-segment elevation resolution category, no additional prognostic information is
obtained. *2 degrees of freedom: TIMI flow grades 0/1 vs. TIMI flow grade 2 and
TIMI flow grades 0/1 vs. TIMI flow grade 3.
CHF 5 congestive heart failure; TIMI 5 Thrombolysis in Myocardial Infarction.
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Clinical implications. The findings of our study must be
considered preliminary. Assuming validation in a larger
patient population, continuous ST-segment monitoring
could provide a noninvasive, inexpensive and reliable
method for monitoring nutritive reperfusion status in AMI
patients. ST-segment monitoring could be utilized for
real-time acute patient care and to obtain highly sensitive
and specific prognostic information independent of TIMI
flow grade in the IRA.
Reprint requests and correspondence: Dr. Akbar Shah, 1380 E.
Stroop Road, Cardiology South, Inc., Kettering, Ohio 45429.
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